Regional Observation of the Metabolic Syndrome

The aim of the study, is to assess the prevalence of metabolic syndrome in Italy on a regional basis, defined according to National Cholesterol Education Program/Adult Treatment Panel III (NCEP/ATPIII) guidelines criteria.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Metabolic Syndrome Cardiovascular Diseases Glucose Metabolism Disorders Hyperinsulinism Hypertension Insulin Resistance Metabolic Diseases Nutritional and Metabolic Diseases Vascular Diseases

Age range

40 year–74 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site

Torino, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Signed informed consent
Laboratory analysis (lipidic profile and glycemia) performed in the last year

Exclusion criteria

Subjects with serious or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's successful participation in the study
Pregnancy or breast feeding
Patients enrolled in clinical studies which the aim is to evaluate the efficacy and/or tolerability of anti-hypertensive and/or lipid lowering drugs

Treatment and study plan

Primary outcomes

Prevalence of metabolic syndrome in primary care population

Time frame: At visit
Concomitant presence of other cardiovascular (CV) risk factors.

Time frame: At visit

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Acronym: ORSA

Important dates

Study start: 2009
Primary completion: 2010
Study completion: 2010
First posted: Apr 3, 2009
Registry last updated: Feb 17, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed